Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.
about
Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymesHIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell cultureAdenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivoMatrix metalloproteinase inhibition. From the Jurassic to the third millennium.Therapeutic potential of ribozymes in haematological disorders.Current status of ribozymes as gene therapy agents for cancer.Synthetic hammerhead ribozymes as tools in gene expression.Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model.The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells.Recent developments in the hammerhead ribozyme field.Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptakeInhibition of hepatitis B virus X gene expression by novel DNA enzymes.The structure, function and application of the hammerhead ribozyme.Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.Recapitulation of the hairless mouse phenotype using catalytic oligonucleotides: implications for permanent hair removal.Gene targeting by ribozyme against TNF-alpha mRNA inhibits autoimmune arthritis.Inhibition of Plasmodium falciparum proliferation in vitro by ribozymes.Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb.
P2860
Q24527367-FF907118-6630-457C-978D-4D5632201432Q30953558-9F776D3A-E3E7-4257-8B02-2EAE6D47F3DDQ33650305-848FEC18-0FB7-4638-9CF7-7FDA3AA1F9DDQ33692943-D0BDCCCD-9E79-4A91-BAA2-B82A1E7E2220Q34074840-BF2B934A-8978-4391-8BBD-E587B4E27D9EQ34311089-6B998C9B-100D-4998-B131-B7704B8BDD95Q34503787-3F62C2EC-59F2-4603-899B-7FD51207FFA2Q36555327-5D03BAD9-11C1-4BCB-8200-895F9FB9E86BQ39719115-FB5269EF-CCD1-4D75-9DA6-15CFCDCF640EQ39725912-BF169FB7-0909-4148-9D4E-236315297029Q39728591-FAE2186A-E53E-447D-AC13-F28EA7ED975FQ40828317-138953BD-CE15-4A4B-932B-C02D5D1751A2Q41453347-745B4FB9-C562-4D71-A748-A0FE67946E68Q45117328-879D2B1D-52C8-4527-B763-0ACA918F6D40Q45873294-DBD32A9B-EF81-4FE7-B430-E8D4EDF66904Q45885240-5C098053-CE76-4E61-9111-2A8CA5D416E1Q48036924-3D1E627C-F6E5-44C3-8666-4E8569BF2584Q48057859-3AB88BFE-4A8D-493B-8981-17A606459A79
P2860
Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@ast
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@en
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@nl
type
label
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@ast
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@en
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@nl
prefLabel
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@ast
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@en
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@nl
P2093
P2860
P356
P1476
Nuclease-resistant ribozymes d ...... us delivery to the knee joint.
@en
P2093
Beigelman L
Hunt SW 3rd
Schrier DJ
Wincott FE
P2860
P304
P356
10.1073/PNAS.93.2.754
P407
P577
1996-01-01T00:00:00Z